Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.36789 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.35911 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.35956 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.31448 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.35162 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.39254 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.35035 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.45059 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.32868 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.34853 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.34391 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.3335 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.34546 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.34123 | 70 |